0001209191-19-021569.txt : 20190328
0001209191-19-021569.hdr.sgml : 20190328
20190328101619
ACCESSION NUMBER: 0001209191-19-021569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190328
FILED AS OF DATE: 20190328
DATE AS OF CHANGE: 20190328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOKICH MICHAEL J
CENTRAL INDEX KEY: 0001235611
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37614
FILM NUMBER: 19710387
MAIL ADDRESS:
STREET 1: C/O STERIS CORP
STREET 2: 5960 HEISLEY RD
CITY: MENTOR
STATE: OH
ZIP: 44060
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STERIS plc
CENTRAL INDEX KEY: 0001624899
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 981203539
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: RUTHERFORD HOUSE
STREET 2: STEPHENSONS WAY
CITY: DERBY
STATE: X0
ZIP: DE21 6LY
BUSINESS PHONE: (440) 354-2600
MAIL ADDRESS:
STREET 1: RUTHERFORD HOUSE
STREET 2: STEPHENSONS WAY
CITY: DERBY
STATE: X0
ZIP: DE21 6LY
FORMER COMPANY:
FORMER CONFORMED NAME: Steris plc
DATE OF NAME CHANGE: 20151102
FORMER COMPANY:
FORMER CONFORMED NAME: New STERIS Ltd
DATE OF NAME CHANGE: 20141125
FORMER COMPANY:
FORMER CONFORMED NAME: Solar New HoldCo Ltd
DATE OF NAME CHANGE: 20141112
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-28
1
0001624899
STERIS plc
STE
0001235611
TOKICH MICHAEL J
C/O RUTHERFORD HOUSE, STEPHENSONS WAY
CHADDESDEN
DERBY
X0
DE21 6LY
UNITED KINGDOM
0
1
0
0
Sr. Vice Pres., CFO
Ordinary Shares, 10 pence par value
2019-03-28
4
D
0
50458
D
0
D
Ordinary Shares, 10 pence par value
2019-03-28
4
D
0
3406
D
0
I
See Footnote Below.
Employee Stock Option (right to buy)
45.34
2019-03-28
4
D
0
22000
D
2023-05-31
Ordinary Shares
22000
0
D
Employee Stock Option (right to buy)
53.52
2019-03-28
4
D
0
28000
D
2024-05-30
Ordinary Shares
28000
0
D
Employee Stock Option (right to buy)
67.98
2019-03-28
4
D
0
20000
D
2025-08-10
Ordinary Shares
20000
0
D
Employee Stock Option (right to buy)
69.72
2019-03-28
4
D
0
30000
D
2026-06-01
Ordinary Shares
30000
0
D
Employee Stock Option (right to buy)
77.07
2019-03-28
4
D
0
32000
D
2027-05-30
Ordinary Shares
32000
0
D
Employee Stock Option (right to buy)
114.22
2019-03-28
4
D
0
46664
D
2028-05-31
Ordinary Shares
46664
0
D
25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022.
Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019.
This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 22,000 ordinary shares of STERIS for $45.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 28,000 ordinary shares of STERIS for $53.52 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option will become exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,000 ordinary shares of STERIS for $67.98 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 30,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 32,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 46,664 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
2019-03-28